Уважаемые коллеги,
как вы уже знаете, компания AbbVie обратилась в Европейский суд с иском против предоставления доступа к данным клинических испытаний для широкого круга исследователей. В результате прогресс в Европе в этом отншении приостановлен.Питер Гоче — один из инициаторов положительного решения ЕВРОСОЮЗА обратился к нам с призывом — подписать коллективное письмо к компании AbbVie. Приглашаю отозваться
ВВВ
Dear co-eds, consumers, methods and fields people,
at the centre directors’ meeting last week I informed about a petition against the outrageous lawsuits Abbvie and InterMune have started against the EMA at the European Court. This lawsuit has sabotaged the EMA’s new openness policy that was a result of the Nordic Cochrane Centre’s complaint to the European ombudsman over the EMA’s refusal to release unpublished clinical study reports and protocols to Cochrane researchers.
The petition was set up by psychiatrist David Healy who has been an expert witness in many US court cases where children have committed suicide caused by antidepressants and not by their disease (some of them did not have any disease at all). Non-disclosure of trial data kills. I therefore hope you will sign the petition and forward this email to as many as possible.
Here is some of what David Healy has said about the petition:
Two years ago, the European ombudsman ruled that the European Medicines Agency should open up access to Clinical Trial Data. Six months ago two American pharmaceutical companies AbbVie and InterMune took a legal action against EMA that has closed down access to all trial data for all drugs. Until recently they were Abbott Laboratories, one of the biggest pharmaceutical companies in the world.
They make Humira, a monoclonal antibody used for Rheumatoid Arthritis, Crohn’s Disease, Psoriasis and other conditions. It is the best selling drug in the world today, and projected to be the best selling drug of all time.
This is one of the most important legal actions in Healthcare ever. At a recent meeting in Bruxelles AbbVie made it clear that a main reason to keep clinical trial data confidential was to hide adverse event data.
You can read about this and see the whole video here ((AbbVie’s statements about adverse events data come after about 23 minutes)
http://davidhealy.org/trade-wars-abbvie-v-china/
If this legal action succeeds Adverse Event data will be hidden for ever. So we’d love you and anyone you know to sign a petition calling on Richard Gonzalez, the CEO of AbbVie to drop his legal action against the EMA’s policy of open access to clinical trial data. The petition is here
or in a range of different languages — Chinese, German, Spanish, French, English and soon Hindi, Swedish and others here —
http://wp.rxisk.org/rxisk-org-koordiniert-die-petition/
bw
Peter
Peter C. Gøtzsche, Professor, Director, MD, DrMedSci, MSc
Nordic Cochrane Centre, Rigshospitalet, Dept. 7811
2100 Copenhagen Ø, Denmark
Visiting address: Tagensvej 22, 1st floor
e-mail: pcg@cochrane.dk, Tel: +45 35 45 71 12, Fax: +45 35 45 70 07
